Trails Edge Capital Partners, LP

Trails Edge Capital Partners, LP reported 38 holdings worth US$696M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Trails Edge Capital Partners, LP reported 38 holdings worth US$696M as of Sep 30, 2026. Largest: LB Pharmaceuticals Inc, BioMarin Pharmaceutical Inc. and Nurix Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
38
Value as reported
US$696M

The filing in full

CompanySharesValue as reported% of portfolio
LB Pharmaceuticals Inc1.15MUS$44.1M6.3%
BioMarin Pharmaceutical Inc.667KUS$40M5.8%
Nurix Therapeutics, Inc.1.57MUS$37.3M5.4%
Obsidian Therapeutics, Inc.2.5MUS$34.3M4.9%
Immunocore Holdings plc1.06MUS$32.2M4.6%
4D Molecular Therapeutics, Inc.2.23MUS$31.9M4.6%
Design Therapeutics, Inc.2.5MUS$31.4M4.5%
Cytokinetics, Incorporated470KUS$31M4.5%
First Tracks Biotherapeutics, Inc.814KUS$28.8M4.1%
Sensei Biotherapeutics, Inc.942KUS$28M4.0%
Tango Therapeutics, Inc.1.1MUS$27.4M3.9%
Neurogene Inc.965KUS$26.8M3.9%
Celldex Therapeutics, Inc.765KUS$24.8M3.6%
Avalo Therapeutics, Inc.1.5MUS$23M3.3%
Contineum Therapeutics, Inc.1.69MUS$22.7M3.3%
Tyra Biosciences, Inc.1MUS$21.9M3.1%
Inhibikase Therapeutics, Inc.9.11MUS$18.7M2.7%
Inhibrx Biosciences, Inc.170KUS$17M2.4%
Xenon Pharmaceuticals Inc.400KUS$14.9M2.1%
CAMP4 Therapeutics Corporation3.63MUS$14.6M2.1%
Altimmune, Inc.4.23MUS$12.1M1.7%
Opus Genetics, Inc.2.41MUS$11.7M1.7%
Kailera Therapeutics, Inc.943KUS$10.8M1.5%
Inventiva SA2.66MUS$9.81M1.4%
Entrada Therapeutics, Inc.1.43MUS$9.07M1.3%
Aura Biosciences, Inc.1.44MUS$9.06M1.3%
Research Alliance Corporation III823KUS$8.91M1.3%
X4 Pharmaceuticals, Inc.2.57MUS$7.46M1.1%
Century Therapeutics, Inc.4.13MUS$7.07M1.0%
ProMIS Neurosciences Inc.557KUS$6.04M0.87%
Research Alliance Corporation IV500KUS$6M0.86%
ImageneBio, Inc.1.09MUS$5.01M0.72%
Minerva Neurosciences, Inc1.42MUS$4.75M0.68%
TCGX Acquisition Corp.250KUS$3.13M0.45%
vTv Therapeutics Inc.76,989US$2.37M0.34%
OnKure Therapeutics, Inc.620KUS$1.69M0.24%
Insmed Incorporated0US$00.00%
Mirum Pharmaceuticals, Inc.0US$00.00%
Revolution Medicines, Inc.0US$00.00%
Syndax Pharmaceuticals, Inc.0US$00.00%
Forte Biosciences, Inc.0US$00.00%
Incyte Corporation0US$00.00%

Source

Download original · View original at SEC

Related